The purpose was to evaluate whether a scalp-recorded slow potential will show specificity during the anticipation of different types of visual tasks. One of the tasks required the comparison of pairs of familiar faces, and the other was the comparison of abstract dotted patterns. Each trial began with one of the two cues (S1) followed by consecutive pictures (S2 and S3). Faces and patterns were superimposed, and the switching between tasks depended on the cue. The ERP analysis was done for the time window between S1 (cue) and S2 presentations. The major differences between tasks were found in the anterior scalp regions starting at 700 ms from S1 onset. During Pattern task anticipation, the proposed sources in the right frontal area were more anterior, inferior and lateral than those in Face task. The task-specific slow electric potentials may indicate the functional specialization for attentive anticipation in the human frontal lobe.

Keywords:
Face recognition, Pattern recognition, High-resolution EEG, Equivalent electric dipole, Source localization
This content is only available via PDF.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.